OAKMONT CORPORATION
OAKMONT CORPORATION is a Series C+ and buyout fund in the US and latin-america investing in biotech-life-science, real-estate and private-equity.
- Stages
- Series C+, buyout
- Sectors
- biotech-life-science, real-estate, private-equity
- Invests in
- US-wide, latin-america
- Actively investing
- Yes
- Founded
- 1980
- Assets under management
- $2.23B
Check size not disclosed
Thesis
The firm actively invests in private equity and private real estate, deploying capital across public equities, private markets, and direct real estate holdings, including hedge funds, private equity, real estate, and venture positions. Their geographic focus is primarily North America, with additional activity in Latin America. The firm has a strategic focus on the biotech/life science sector and employs a buyout strategy. They also manage a discretionary AUM of $0.4 billion.
Common questions
Does OAKMONT CORPORATION invest at the Series C+ stage?
Yes. OAKMONT CORPORATION lists Series C+ and buyout among the stages it invests in.
Where does OAKMONT CORPORATION invest?
OAKMONT CORPORATION invests in the US and latin-america.